To clarify the specific role of opioids compared to placebo or other analgesics in the management of patient with chronic noncancer pain, Jason Busse, McMaster University, and Canadian Co Director of CIM led an international systematic review. 96 high quality randomized studies showed only minimal benefits for patients.